JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article

J Thorac Cardiovasc Surg 2007;133:1316-1317
© 2007 The American Association for Thoracic Surgery


Surgery for Congenital Heart Disease

Discussion

The first 20% of the full text of this article appears below.

Dr Lamberti (San Diego, Calif). Dr Hawkins and his colleagues have reported their results for aortic or systemic semilunar valve repair in infants and children since 1991. If we look back over the past 20 years, we can identify 2 other operations that were proposed for aortic valve disease in infants and children that have not withstood the test of time. After 1985, aortic homograft valves were generally available for use in infants and children. In addition, the general availability of homograft valves led to enthusiasm for the Ross operation as a potentially curative operation for children. At the meeting of this association in June 1992 in Kauai, Hawaii, Dr David Clarke reported on his extensive experience with aortic valve homografts in young patients. Dr Clarke reported that cryopreserved aortic valve homografts degenerated rather quickly in infants and children less than 3 years of age. For many of us the Ross operation seemed to offer an excellent option for the treatment of important aortic valve disease in infants, children, and young adults. Mid- to long-term follow-up of patients undergoing the Ross operation has not supported the concept that replacing the aortic valve with the native pulmonary valve with the technique of root replacement is a durable substitute for the aortic valve. Today the surgeon confronted with a severe case of systemic semilunar valve insufficiency has no ideal option for treatment, particularly in infants and small children. Although the neonatal Ross operation can save the life of an infant, the patient will face multiple reoperations on the right ventricular outflow tract and the possibility that late replacement of the aortic graft will be . . . [Full Text of this Article]


Related Article

Intermediate-term results of repair for aortic, neoaortic, and truncal valve insufficiency in children
John A. Hawkins, Peter C. Kouretas, Richard Holubkov, Richard V. Williams, Lloyd Y. Tani, Jason T. Su, Linda M. Lambert, Christopher R. Mart, Michael D. Puchalski, and L. LuAnn Minich
J. Thorac. Cardiovasc. Surg. 2007 133: 1311-1317. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The American Association for Thoracic Surgery.